Showing results (71-80 of 133) with videos related to

Sort By:
Pageof 14
Genome Medicine|September 18, 2023
Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrenceShuming Zhang, Long Yuan, Ludmila Danilova, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
Informing virtual clinical trials of hepatocellular carcinoma with spatial multi-omics analysis of a human neoadjuvant immunotherapy clinical trialShuming Zhang, Atul Deshpande, Babita K Verma, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrenceShuming Zhang, Long Yuan, Ludmila Danilova, et al.
Cancer Research|June 11, 2024
Integration of Clinical Trial Spatial Multiomics Analysis and Virtual Clinical Trials Enables Immunotherapy Response Prediction and Biomarker DiscoveryShuming Zhang, Atul Deshpande, Babita K Verma, et al.
JCO Precision Oncology|June 8, 2022
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune SignaturesKabir Mody, Prerna Jain, Sherif M El-Refai, et al.
Journal of the Neurological Sciences|August 28, 2013
Association of plasma C-reactive protein levels with the diagnosis of Alzheimer's diseaseMark Yarchoan, Natalia Louneva, Sharon X Xie, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Preventing NK cell activation in the damaged liver induced by cabozantinib/PD-1 blockade increases survival in hepatocellular carcinoma modelsSatoru Morita, Hiroto Kikuchi, Grace Birch, et al.
Oncotarget|April 29, 2017
Olaparib in combination with irinotecan, cisplatin, and mitomycin C in patients with advanced pancreatic cancerMark Yarchoan, Melinda C Myzak, Burles A Johnson, et al.
JCI Insight|October 19, 2018
Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancerHeather L Kinkead, Alexander Hopkins, Eric Lutz, et al.
Cell Reports. Medicine|August 29, 2024
Proteo-metabolomics and patient tumor slice experiments point to amino acid centrality for rewired mitochondria in fibrolamellar carcinomaDonald Long, Marina Chan, Mingqi Han, et al.
Pageof 14